title: Differential decrease of the central beta-adrenergic receptor in the rat after subchronic infusion of desipramine and clenbuterol.
abstract: The effect of subchronic infusion of desipramine, a norepinephrine uptake inhibitor, and clenbuterol, a beta-adrenergic agonist, on the central beta receptor of the rat was determined using in vitro [(3)H]dihydroalprenolol binding. Desipramine produced significant decreases of the receptor in neocortex and hippocampal formation, and clenbuterol effected such decreases in corpus striatum and cerebellum. Both drugs caused a marked decrease in the activity of isoproterenol-sensitive adenylate cyclase in neocortex. The alpha(2) receptor of neocortex and cerebellum was unchanged by either drug as assessed by in vitro[ (3)H ]p- aminoclonidine binding. The results are discussed in terms of the different mechanisms of action of desipramine and clenbuterol, and the efficacy of these two drugs in the treatment of depression.
authors.affiliation: Research Department, Pharmaceuticals Division, CIBA-GEIGY Ltd., CH-4002 Basel, Switzerland.
authors.forename: D J
authors.initials: DJ
authors.lastname: Dooley
authors.forename: K L
authors.initials: KL
authors.lastname: Hauser
authors.forename: H
authors.initials: H
authors.lastname: Bittiger